| abstract |
The invention concerns amide derivatives of Formula (I), wherein R<SUP>3 </SUP>is (1-6C)alkyl or halogeno; m is 1-3 and R<SUP>1 </SUP>is selected from substituents such as: (A) hydroxy, halogeno, (1-6C)alkyl, (1-6C)alkoxy, aryl, heteroaryl and heterocyclyl; and (B) di-[(1-6C)alkyl]amino-(1-6C)alkyl, (1-6C)alkoxy-(2-6C)alkoxy, di-[(1-6C)alkyl]amino-(2-6C)alkoxy, aryloxy, heteroaryloxy, heteroaryl-(1-6C)alkoxy, heterocyclyloxy and heterocyclyl-(1-6C)alkoxy; p is 0-2 and R<SUP>2 </SUP>is a substituent such as hydroxy and halogeno; q is 0-4; and R<SUP>4 </SUP>is aryl or cycloalkyl which bears 1-3 substituents such as: (C) hydrogen, hydroxy, halogeno and heterocyclyl; and (D) heteroaryl-(1-6C)alkoxy and heterocyclyl-(1-6C)alkoxy, provided that a substituent on R<SUP>4 </SUP>is selected from paragraph (C) only if at least one R<SUP>1 </SUP>group is selected from paragraph (B); processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of diseases or medical conditions mediated by cytokines. |